Participants in the study will need to follow study instructions, participate in study visits, and undergo specific medical tests.
What’s the medication and how long is the study treatment?
Screening:
Up to 21 days.
Treatment: 28 days
Taper:10 days
Follow Up:
Up to 14 days
The study drug is rectal suppository. Each suppository is packaged with a disposable Sephure suppository applicator
Not all participants will receive the study drug. Some patients will receive placebo drug that looks like the study drug but contains no active ingredient.
How many study visits are involved?
Up to 7 office visits
2 telephone calls
What medical tests are included?
A test to examine the lining of the colon. A sigmoidoscopy is a test to examine the lowest portion of the colon.
An Electrocardiogram (ECG) is a test to evaluate your heart for possible signs of heart disease.
Want to know if you can participate? click here
Currently recruiting at clinical research sites around the world.
To find a research site near you, please click here
Cristcot HCA LLC 9 Damonmill Square, Suite 4A, Concord, MA 01742 USA
privacy policy | terms of use
cessa is the name of an ongoing clinical trial for people with ulcerative colitis.
It is not a commercially available treatment.
If you are experiencing symptoms related to IBD, contact your gastroenterologist.